References:
1. Yach D, Hawkes C, Gould CL, Hofman KJ. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA 2004;291(21):2616-22.
2. Liccardi G, Salzillo A, Calzetta L, Cazzola M, Matera MG, Rogliani P. Can bronchial asthma with an highly prevalent airway (and systemic) vagal tone be considered an independent asthma phenotype? Possible role of anticholinergics. Respir Med 2016;117:150-3.
3. Szekely JI, Pataki A. Recent findings on the pathogenesis of bronchial asthma. Part II. The role of hormonal predisposition, environmental influences and conditioning leading to bronchial asthma. Acta Physiol Hung 2009;96(3):289-305.
4. Lutz W, Sulkowski WJ. Vagus nerve participates in regulation of the airways: inflammatory response and hyperreactivity induced by occupational asthmogens. Int J Occup Med Environ Health 2004;17(4):417-31.
5. Liu R, Song J, Li H, Wu Z, Chen H, Wu W, et al. Treatment of canine asthma by high selective vagotomy. J Thorac Cardiovasc Surg 2014;148(2):683-9.
6. Buhl R, Hamelmann E. Future perspectives of anticholinergics for the treatment of asthma in adults and children. Ther Clin Risk Manag 2019;15:473-485.
7. Gudovskii LM, Karashurov SE, Karashurov ES, Volkov AA, Parshin VD. [Surgical treatment of bronchial asthma]. Khirurgiia (Mosk) 2002(7):14-8.
8. Chen X, Zeng M, He D, Yan X, Chen H, Chen Y, et al. Asthmatic Augmentation of Airway Vagal Activity Involves Decreased Central Expression and Activity of CD73 in Rats. ACS Chem Neurosci 2019;10(6):2809-2822.
9. Thomson NC. Clinical Studies of Statins in Asthma and COPD. Curr Mol Pharmacol 2017;10(1):60-71.
10. Zeki AA, Elbadawi-Sidhu M. Innovations in asthma therapy: is there a role for inhaled statins? Expert Rev Respir Med 2018;12(6):461-473.
11. Al-Sawalha NA, Knoll BJ. Statins in Asthma: A Closer Look into the Pharmacological Mechanism of Action. Pharmacology 2016;98(5-6):279-283.
12. Bhattacharjee D, Chogtu B, Magazine R. Statins in Asthma: Potential Beneficial Effects and Limitations. Pulm Med 2015;2015:835204.
13. So JY, Dhungana S, Beros JJ, Criner GJ. Statins in the treatment of COPD and asthma-where do we stand? Curr Opin Pharmacol 2018;40:26-33.
14. Zhang XJ, Qin JJ, Cheng X, Shen L, Zhao YC, Yuan Y, et al. In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19. Cell Metab 2020.
15. Obata T, Nakashima M. Fluvastatin, an HMG-CoA reductase inhibitor, facilitate adenosine production in the rat hearts via activation of ecto-5’-nucleotidase. Microvasc Res 2016;107:1-5.
16. Ledoux S, Laouari D, Essig M, Runembert I, Trugnan G, Michel JB, et al. Lovastatin enhances ecto-5’-nucleotidase activity and cell surface expression in endothelial cells: implication of rho-family GTPases. Circ Res 2002;90(4):420-7.
17. Meijer P, Oyen WJ, Dekker D, van den Broek PH, Wouters CW, Boerman OC, et al. Rosuvastatin increases extracellular adenosine formation in humans in vivo: a new perspective on cardiovascular protection. Arterioscler Thromb Vasc Biol 2009;29(6):963-8.
18. Zukowska P, Kutryb-Zajac B, Toczek M, Smolenski RT, Slominska EM. The role of ecto-5’-nucleotidase in endothelial dysfunction and vascular pathologies. Pharmacol Rep 2015;67(4):675-81.
19. Meijer P, Wouters CW, van den Broek PH, de Rooij M, Scheffer GJ, Smits P, et al. Upregulation of ecto-5’-nucleotidase by rosuvastatin increases the vasodilator response to ischemia. Hypertension 2010;56(4):722-7.
20. Osman L, Amrani M, Ilsley C, Yacoub MH, Smolenski RT. Atorvastatin accelerates extracellular nucleotide degradation in human endothelial cells. Mol Cell Biochem 2008;308(1-2):209-17.
21. Osman L, Amrani M, Isley C, Yacoub MH, Smolenski RT. Stimulatory effects of atorvastatin on extracellular nucleotide degradation in human endothelial cells. Nucleosides Nucleotides Nucleic Acids 2006;25(9-11):1125-8.
22. He D, Chen H, Zeng M, Xia C, Wang J, Shen L, et al. Asthmatic Airway Vagal Hypertonia Involves Chloride Dyshomeostasis of Preganglionic Neurons in Rats. Front Neurosci 2020;14:31.
23. ”Global strategy for asthma management and prevention: GINA executive summary.” E.D. Bateman, S.S. Hurd, P.J. Barnes, J. Bousquet, J.M. Drazen, J.M. FitzGerald, P. Gibson, K. Ohta, P. O’Byrne, S.E. Pedersen, E. Pizzichini, S.D. Sullivan, S.E. Wenzel and H.J. Zar. Eur Respir J 2008; 31: 143-178. Eur Respir J 2018;51(2).
24. Wu KL, Hung CY, Chan JY, Wu CW. An increase in adenosine-5’-triphosphate (ATP) content in rostral ventrolateral medulla is engaged in the high fructose diet-induced hypertension. J Biomed Sci 2014;21:8.